We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 08 JULY 2013
Supreme Court Subjects Reverse Payment Settlements To Antitrust Review
Reed Smith
In a recent opinion with powerful implications for drug manufacturers, the U.S. Supreme Court decided in FTC v. Actavis that reverse payment settlement agreements can violate the antitrust laws despite the antitrust immunity provided by patents and public policy favoring settlement.
United StatesAntitrust/Competition Law












